FDA panel recommends GSK’s vaccine against RSV

The Food and Drug Administration’s (FDA) independent advisory panel endorsed on Wednesday GlaxoSmithKline’s respiratory syncytial virus (RSV) vaccine for adults over 60.

Ten FDA assessors agr…